Neurosciences articles for Harvard University, United States of America (USA)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 138

Article ‘Count’ for Neurosciences.

Journal Count Share
1 0.06
Near-Infrared Chemiluminescence Probe for Superoxide Anion Imaging in Alzheimer’s Disease 0.06
1 1.00
Early Intensive Blood Pressure Reduction After Intracerebral Hemorrhage Is Associated With Worse Functional Outcome: The Risk of Overshooting Blood Pressure Goals 1.00
1 0.06
Action Collaborative on Traumatic Brain Injury Care: Adapted Clinical Practice Guideline 0.06
20 4.17
Shotgun Metagenomic Profiling of the Gut Virome in Prodromal and Confirmed Parkinson's Disease 0.73
AI-Driven Mapping of Seizure Spread Patterns 0.02
Cerebrospinal Fluid Amyloid‐β Biomarkers Predict Future Hemorrhage in Patients with Cerebral Amyloid Angiopathy 0.06
Multimodal Image Guidance in Subthalamic Deep Brain Stimulation for Parkinson's Disease 0.19
Distinct Prescription Patterns Emerge Years Before ALS Diagnosis: A Nationwide Registry-Based Study 0.29
Primary Lateral Sclerosis Natural History Study: Primary Lateral Sclerosis Functional Rating Scale and Other Outcomes Assessment 0.08
Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling 0.01
Probabilistic Lesion Mapping to Optimize Thalamotomy Targets for Focal Hand Dystonia 0.50
Additive Effects of White Matter Hyperintensity and APOE ε4 Status on Risk of Incident Dementia in Two Large Longitudinal Cohorts 0.19
Polygenic Vulnerability to Intracranial Hypertension, Hemorrhage Progression, and Outcome in Traumatic Brain Injury 0.05
Real‐World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease‐Modifying Therapy in Pediatric Multiple Sclerosis 0.11
Mutations in the Key Autophagy Tethering Factor scpEPG5/scp Link Neurodevelopmental and Neurodegenerative Disorders Including Early‐Onset Parkinsonism 0.02
Skeletal Muscle Biomarkers of Amyotrophic Lateral Sclerosis: A Large‐Scale, Multi‐Cohort Proteomic Study 0.06
scpMarkVCID2/scp Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics 0.18
iHCN2/i‐Associated Neurodevelopmental Disorders: Data from Patients and iXenopus/i Cell Models 0.04
Intravenous Glyburide in Medical and Endovascular‐Treated Large‐Core Stroke: A Subgroup Analysis of the scpCHARM/scp Randomized Clinical Trial 0.17
Clinical and Cognitive Profiles of Individuals with Alzheimer's Disease and Comorbid Seizures 0.10
Brain Endothelial Soluble scpST2/scp Production and Cerebral Edema in a Rat Model of Ischemic Stroke 0.89
Toward a Universal Map of EEG: A Semantic, Low‐Dimensional Manifold for scpEEG/scp Classification, Clustering, and Prognostication 0.40
μ‐Opioid Receptor Dynamics in the Parameningeal Tissue During Migraine Attacks 0.09
4 0.46
A Novel Examination of the Impact of Time and Reliability on Minimal Detectable Differences Using the Coma Recovery Scale – Revised 0.19
New Diagnostic Criteria for Mild Traumatic Brain Injury: Medical-Legal Considerations 0.09
Predicting Suicidality in Veterans/Service members over 5 Years after TBI: A VA Model Systems Study 0.10
Primary Care and Brain Injury Physician Utilization for Persons Living with Chronic Brain Injury 0.08
8 2.91
Evidence of skull bone translocator protein overexpression linked to multiple sclerosis progression 0.59
The deep brain stimulation response network in Parkinson’s disease operates in the high beta band 0.34
Elucidating the nociceptive role of CGRP in migraine headache 1.00
Brain signatures of nociplastic pain: Fibromyalgia Index and descending modulation at population level 0.06
Molecular and clinical spectrum of epilepsy-dyskinesia syndromes: a cross-sectional study of 609 patients 0.23
Activation and sensitization of meningeal nociceptors by PACAP-38: implications for migraine headache 0.60
Proprioceptive synaptic dysfunction is a key feature in mice and humans with spinal muscular atrophy 0.04
Charcot-Marie-Tooth disease type 1E: clinical natural history and molecular impact of iPMP22/i variants 0.04
3 0.38
IL-1R1-positive dorsal raphe neurons drive self-imposed social withdrawal in sickness 0.07
Microglia-astrocyte crosstalk regulates synapse remodeling via Wnt signaling 0.04
In vivo prime editing rescues alternating hemiplegia of childhood in mice 0.28
1 0.43
Notch3 destabilizes regulatory T cells to drive autoimmune neuroinflammation in multiple sclerosis 0.43
2 0.13
Multivariate Brain-Blood Signatures in Early-Stage Depression and Psychosis 0.00
Symptom Provocation and Clinical Response to Transcranial Magnetic Stimulation 0.13
6 1.17
Intravenous Tenecteplase Prior to Endovascular Treatment for Ischemic Stroke at 4.5 to 24 Hours 0.04
Levodopa Added to Stroke Rehabilitation 0.01
In Utero Embolization for Fetal Vein of Galen Malformation 0.95
Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours 0.02
Influenza-Associated Acute Necrotizing Encephalopathy in US Children 0.08
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity 0.06
1 0.33
Alzheimer’s disease-linked ACE variants increase ACE1 catalytic activity and production of angiotensin II 0.33
2 0.72
MRI Assessment of Median Nerve Size in Patients with Proximate Electrodiagnostic Studies. 0.64
The Utility of a Prediction Model Using Neurological Examination Findings for Diagnosing Degenerative Cervical Myelopathy. 0.08
1 0.01
Biallelic variants in ARHGAP19 cause a progressive inherited motor-predominant neuropathy 0.01
2 0.26
Aberrant Cerebellar-Recipient Thalamic Activity in Two Mouse Models with Prominent Tremor or Bradykinesia 0.20
Alzheimer’s Disease Pathologies Affect Dopaminergic Neural Mechanisms of Memory 0.06
1 1.00
Functional role of Nav1.8 channels in action potentials of mouse CGRP‐lineage dorsal root ganglion neurons 1.00
1 0.04
Electric Double Layer Phenomena Near Surfaces Irreversibly Trigger Assembly of Tau Protein 0.04
1 0.14
Characterization of National Institute on Aging‐Funded Clinical Trials for Alzheimer's Disease 0.14
1 0.17
α-Synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation 0.17
3 2.17
Circuit-targeted modulation of anxiety symptoms in individuals with major depression: A randomized head-to-head TMS trial 0.95
Predictive value of subgenual cingulate normative connectivity to TMS treatment site for antidepressant response in routine clinical practice: a prospective, multisite cohort study 0.85
White matter disconnection in acquired criminality 0.37
1 0.13
DNA Nanostructures for Modular Growth Factor Delivery and Peripheral Nerve Repair 0.13
4 0.37
Parkinson’s disease as a somato-cognitive action network disorder 0.11
A probabilistic histological atlas of the human brain for MRI segmentation 0.12
Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis 0.11
Microglia–neuron crosstalk via Hex–GM2–MGL2 maintains brain homeostasis 0.03
1 0.12
Riboflavin metabolism shapes FSP1-driven ferroptosis resistance 0.12
20 4.32
Thalamo-cortical synchrony shapes seizure expression in human temporal lobe epilepsy 0.07
Genotype epigenome phenotype integration reveals peripheral immune contributions to type I bipolar disorder 0.09
Double strand breaks drive toxicity in a Huntington’s disease mouse model with or without somatic expansion 0.33
In vivo imaging of central nervous system fluid spaces using synchrotron radiation-based micro computed tomography 0.02
Efficacy and safety of albumin combined with endovascular therapy in the treatment of patients with acute ischemic stroke: a randomized clinical trial 0.03
Renal coenzyme A (CoA) production from VB5 fuels stem cell proliferation and tumor growth 1.00
Single-nucleus brain transcriptomics reveals microglia dysfunction in multiple system atrophy 0.04
Multi-modal dissection of cell-type specific TDP-43 pathology in the motor cortex 0.09
A 3D gut-brain-vascular platform for bidirectional crosstalk in gut-neuropathogenesis 0.03
Suppression of Huntington’s Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding 0.18
Age modulates the link between stress-related neural activity and mortality 0.02
Sex-specific associations of gene expression with Alzheimer’s disease neuropathology and ante-mortem cognitive performance 0.20
Integrating artificial intelligence and optogenetics for Parkinson’s disease diagnosis and therapeutics in male mice 0.19
Regional heterogeneity of the blood-brain barrier 0.13
A human brain network linked to restoration of consciousness after deep brain stimulation 0.65
Mechanically robust neuroprotective stent by sequential Mg ions release for ischemic stroke therapy 0.06
Intraoperative nerve-specific fluorescence visualization in head and neck surgery: a Phase 1 trial 0.11
FABP7 is increased in progressive multiple sclerosis and induces a pro-inflammatory phenotype in monocytes through a glycolytic switch 1.00
Noncanonical short-latency auditory pathway directly activates deep cortical layers 0.06
TGFα controls checkpoints in CNS resident and infiltrating immune cells to promote resolution of inflammation 0.03
2 1.32
Somatic mosaicism in ALS and FTD identifies focal mutations associated with widespread degeneration 0.78
Genetic modifiers of somatic expansion and clinical phenotypes in Huntington’s disease highlight shared and tissue-specific effects 0.54
2 0.23
A spatially coordinated keratinocyte–fibroblast circuit recruits MMP9⁺ myeloid cells to drive type I interferon-driven inflammation in photosensitive autoimmunity 0.18
A transcriptomic microglia taxonomy across mouse and human pathologies 0.05
2 0.19
Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial 0.07
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial 0.11
11 2.94
Neuroproteasomes regulate endogenous tau paired helical filament formation in an genotype- and age-dependent manner 0.14
Adversarial AI reveals mechanisms and treatments for disorders of consciousness 0.01
Circuit response to neuromodulation characterized with simultaneous deep brain stimulation and precision neuroimaging in humans 0.04
Base barrier cells provide compartmentalization of choroid plexus, brain and CSF 0.14
Phosphorylated tau exhibits antimicrobial activity capable of neutralizing herpes simplex virus 1 infectivity in human neurons 0.82
TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD 0.17
Region-specific drivers of CSF mobility measured with MRI in humans 0.08
Hormonal milieu influences whole-brain structural dynamics across the menstrual cycle using dense sampling in multiple individuals 0.07
Hypoxia ameliorates neurodegeneration and movement disorder in a mouse model of Parkinson’s disease 0.68
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, genotype and sex 0.03
Protective exercise responses in the dentate gyrus of Alzheimer’s disease mouse model revealed with single-nucleus RNA-sequencing 0.77
5 1.83
Alzheimer’s disease pathology degrades an NMDA receptor-dependent spontaneous activity pattern in cortico-hippocampal circuits 0.18
Sex-specific APOE4-dependent innate immunity regulates meningeal lymphatics, brain lipids, neuroinflammation, and cognition 0.05
A dorsal hippocampus-prodynorphinergic dorsolateral septum-to-lateral hypothalamus circuit mediates contextual gating of feeding 0.55
The gain-of-function TREM2-T96K mutation increases risk for Alzheimer’s disease by impairing microglial function 1.00
In vivo 7 Tesla MRI of non-human primate intracortical microvascular architecture 0.06
1 1.00
Peripapillary hyperreflective ovoid mass-like structures before and after intracranial decompression: a longitudinal cohort study 1.00
1 1.00
The Drosophila G protein-coupled receptor, GulpR, is essential for lipid mobilization in response to nutrient-limitation 1.00
12 4.99
Cytotoxic T cell recognition of α-synuclein drives pathogenic immune responses in multiple system atrophy 0.27
Fatty acid regulation of feeding in Caenorhabditis elegans reveals the potential ancestral origin of a GLP-1-like multiagonist signaling system 0.60
Inorganic phosphate and the rapid mobilization of metabolic energy in neurons 0.94
ODC1 restricts meningeal B cell age-associated-like phenotype and function in multiple sclerosis: A human and experimental study 0.45
Huntington’s disease LIG1 modifier variant increases ligase fidelity and suppresses somatic CAG repeat expansion 0.80
Highly sensitive chemiluminescence imaging of misfolded proteins in neurodegenerative models 0.42
Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection 0.07
Preservation of anticorrelated brain networks predicts recovery after traumatic brain injury 0.29
Neurofluid circulation changes during a focused attention style of mindfulness meditation 0.11
Full interhemispheric integration sustained by a fraction of posterior callosal fibers 0.02
Activity-dependent citrate dynamics in neurons 0.56
Fluid dynamics model of the cerebral ventricular system 0.48
1 0.82
Brain MRI Analysis of Cumulative Blast Exposure and Intracranial Aneurysms in Special Operations Forces. 0.82
2 0.66
Luminal surface proteome of the brain vasculature uncovers blood-brain barrier regulators 0.10
Blocking RAN translation without altering repeat RNAs rescues C9ORF72-related ALS and FTD phenotypes 0.56
5 0.82
α-Synuclein expression is required for somatodendritic dopamine release and immediate early gene induction 0.17
Identification and characterization of botulinum neurotoxin–like two-component toxins in Paeniclostridium ghonii 0.39
Differential modulation of movement speed with state-dependent deep brain stimulation in Parkinson’s disease 0.03
A nut-and-bolt assembly of the bimodular large progenitor botulinum neurotoxin complex 0.01
SARS-CoV-2 induces Alzheimer’s disease–related amyloid-β pathology in ex vivo human retinal explants and retinal organoids 0.22
3 1.45
A platform for near real-time and multiplexed monitoring of cerebrospinal fluid biomarkers and flow in neurocritical care 0.15
In vivo adenine base editing ameliorates Dravet syndrome phenotypes in a mouse model 0.35
Type I interferon limits central nervous system autoimmunity by modulating the microRNA-21–FOXO1 axis in pathogenic T helper 17 cells 0.95
2 0.06
Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials 0.03
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial 0.03
3 0.26
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1 Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial 0.10
Association between the Edinburgh CT and genetic diagnostic criteria for cerebral amyloid angiopathy-associated lobar intracerebral haemorrhage and recurrent intracerebral haemorrhage: an individual patient data meta-analysis 0.11
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial 0.04

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.